Drug
Reboxetine clinical trials
Also written Edronax®.
- studies test it
- 30
- open now
- 3
- in phase 3
- 7
- first study started
- 2003
Keep track of what changes. Save the Reboxetine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
30 studies that test it; most in 2006 (6)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 14
- Phase 3
- 7
- Phase 4
- 2
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 13
Pfizer (13) · Axsome Therapeutics, Inc. (3) · University of Zurich (2) · University of Haifa (2) · Universitätsklinikum Hamburg-Eppendorf (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · University of Oxford (1) · Guiyang Medical University (1)
Often tested with
Tested in the same studies.
Methylphenidate (4) · Sertraline (4) · Citalopram (3) · Rivastigmine (2) · Venlafaxine (2) · Pregabalin (2) · Nicotine Chewing Gum (1) · Triiodothyronine (1)
Studies
Open first, then newest update. How each study uses Reboxetine is read from its arms, and is right about nine times in ten.
Testing it · 30
- The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSDRecruitingPhase 2University of HaifaNCT07771530Written as Reboxetine
- Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSDRecruitingPhase 2University of HaifaNCT05133804Written as Reboxetine
- Reboxetine for Sleep Apnoea After ENT SurgeryRecruitingPhase 2Flinders UniversityNCT05978505Written as Reboxetine 4 MG Oral Tablet
- Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)CompletedPhase 2Axsome Therapeutics, Inc.NCT03881852Written as AXS-12 (Reboxetine)
- A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With NarcolepsyCompletedPhase 3Axsome Therapeutics, Inc.NCT05059223Written as AXS-12 (reboxetine)
- A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)CompletedPhase 3Axsome Therapeutics, Inc.NCT05113745Written as AXS-12 (reboxetine)
- Enhancement of Motor Function with Reboxetine and Transcranial Direct Current StimulationCompletedPhase 4Universitätsklinikum Hamburg-EppendorfNCT00853866Written as reboxetine
- Studying the Role of Brain Molecules for Decision MakingCompletedNot applicableUniversity of ZurichNCT04384562Written as Reboxetine
- A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.CompletedPhase 2Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00636246Written as sertraline/[S,S]-reboxetine
- Noradrenaline, Acetylcholine and Dynamic Learning in Healthy HumansCompletedNot applicableUniversity of OxfordNCT03957174Written as Reboxetine
- The Role of Dopaminergic and Noradrenergic Neurotransmission in Value- and Salience-based Decision-MakingCompletedNot applicableUniversity of ZurichNCT04371146Written as Reboxetine
- Open Label Extension Study of [S,S]-Reboxetine in Patients With FibromyalgiaTerminatedPhase 3PfizerNCT00754221Written as [S,S]-Reboxetine
- [S,S]-Reboxetine Add-On TrialTerminatedPhase 2PfizerNCT00334685Written as [S,S]-Reboxetine + Pregabalin
- Long-term OL Study of [S,S]-RBX in Patients With FibromyalgiaTerminatedPhase 3PfizerNCT00607256Written as [S,S]-reboxetine
- A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.TerminatedPhase 2PfizerNCT00625833Written as [S,S]-Reboxetine
- A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.CompletedPhase 3PfizerNCT00612170Written as [S,S]-Reboxetine
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnPhase 2PfizerNCT00562055Written as PNU-165442G; [S,S]-reboxetine
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Reboxetine
- Antidepressants and Bone Mineral DensityCompletedPhase 3Guiyang Medical UniversityNCT02179268Written as reboxetine
- A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With FibromyalgiaCompletedPhase 2PfizerNCT00357825Written as [S,S]-Reboxetine
See all 30 studies that test Reboxetine →
As the comparator · 2 — what is tested is compared with Reboxetine
- Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female SubjectsCompletedPhase 1University Hospital Bispebjerg and FrederiksbergNCT04097288Written as Reboxetine 8 mg
- Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive DisorderStatus unknownPhase 4Hospital Universitari Vall d'Hebron Research InstituteNCT00209807Written as Reboxetine
Codes
What other systems call Reboxetine · ClinicalTrials.gg INT006767
- MeSH (NLM) D000077593ReboxetineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 947S0YZ36IREBOXETINEConfirmed FDA, NLM, Wikidata
- RxNorm 60842One source FDA
- Wikidata Q418970(RS,RS)-reboxetineConfirmed FDA, NLM, Wikidata
- Wikidata Q72506458(R,R)-reboxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72838ReboxetineOne source FDA
- DrugBank DB00234One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077593 | Reboxetine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 947S0YZ36I | REBOXETINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 60842 | — | One source FDA |
| Wikidata | Q418970 | (RS,RS)-reboxetine | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q72506458 | (R,R)-reboxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72838 | Reboxetine | One source FDA |
| DrugBank | DB00234 | — | One source Wikidata |
Also registered as reboxetine mesylate (UNII L94J81YNNY · RxNorm 60841).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.